ZBAR BRETT I W Insider Trades

Insider Trading History

Track insider trading activity for ZBAR BRETT I W. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Centessa Pharmaceuticals plc
Centessa Pharmaceuticals plc CNTA
Director
Holding Value $0 0 shares
Last Trade
Jun 24, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$10.1M 248,570 shares
$40.50
$40.50
Centessa Pharmaceuticals plc
Centessa Pharmaceuticals plc CNTA
Director
Holding Value $1.62M 40,000 shares
Last Trade
Jun 20, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$497k 40,000 shares
$12.43
$40.50
Centessa Pharmaceuticals plc
Centessa Pharmaceuticals plc CNTA
Director
Holding Value $1.94M 48,000 shares
Last Trade
Jun 25, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$427k 48,000 shares
$8.89
$40.50
Centessa Pharmaceuticals plc
Centessa Pharmaceuticals plc CNTA
Director
Holding Value $1.94M 48,000 shares
Last Trade
Jun 22, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$305k 48,000 shares
$6.35
$40.50
Centessa Pharmaceuticals plc
Centessa Pharmaceuticals plc CNTA
Director
Holding Value $1.94M 48,000 shares
Last Trade
Jun 30, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$234k 48,000 shares
$4.87
$40.50
Centessa Pharmaceuticals plc
Centessa Pharmaceuticals plc CNTA
Director
Holding Value $2.62M 64,570 shares
Last Trade
Jul 01, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.46M 64,570 shares
$22.55
$40.50

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up